Harvest One Cannabis (TSXV: HVT) (OTCQX: HRVOF) has introduced a new CBD food supplement.

The CBD oil, Satipharm Lemon & Lime, is formulated to address three major concerns from consumers: taste, GMP certification, and reliable dosage, according to a company statement.

The Satipharm Lemon & Lime CBD oil is available to customers across Europe through the online store of the company’s subsidiary Satipharm. Brick and mortar distribution will follow with major retailers throughout Europe.

Satipharm expects to expand the new European oils program with more varieties in the coming months.

Satipharm CBD oils join the existing CBD Gelpell capsules, already available across Europe online and in 1,800 stores across the UK and Ireland. All of Satipharm’s products in Europe are EU GMP certified.

“Product innovation is essential to building our brands. Our new CBD oil illustrates continued movement by Harvest One towards our strategy of building health, wellness, and self-care brands around the world,” Harvest One CEO Grant Froese stated. “Customers can have the same confidence in new Satipharm CBD oils as they do in our existing Satipharm CBD Gelpell® already on the market across Europe.”